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Abstract
 
It is thought that both helper and effector functions of CD4
 
 
 
 T cells contribute to protective
immunity to blood stage malaria infection. However, malaria infection does not induce long-
term immunity and its mechanisms are not defined. In this study, we show that protective para-
site-specific CD4
 
 
 
 T cells were depleted after infection with both lethal and nonlethal species of
rodent 
 
Plasmodium
 
. It is further shown that the depletion is confined to parasite-specific T cells
because (a) ovalbumin (OVA)-specific CD4
 
 
 
 T cells are not depleted after either malaria infec-
tion or direct OVA antigen challenge, and (b) the depletion of parasite-specific T cells during
infection does not kill bystander OVA-specific T cells. A significant consequence of the deple-
tion of malaria parasite–specific CD4
 
 
 
 T cells is impaired immunity, demonstrated in mice that
were less able to control parasitemia after depletion of transferred parasite-specific T cells. Using
tumor necrosis factor (TNF)-RI knockout– and Fas-deficient mice, we demonstrate that the
depletion of parasite-specific CD4
 
 
 
 T cells is not via TNF or Fas pathways. However, in vivo
administration of anti–interferon (IFN)-
 
 
 
 antibody blocks depletion, suggesting that IFN-
 
 
 
 is
involved in the process. Taken together, these data suggest that long-term immunity to malaria
infection may be affected by an IFN-
 
 
 
–mediated depletion of parasite-specific CD4
 
 
 
 T cells
during infection. This study provides further insight into the nature of immunity to malaria and
may have a significant impact on approaches taken to develop a malaria vaccine.
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Introduction
 
CD4
 
 
 
 T cells play a critical role in protective immunity to
blood stage malaria parasite infection. This has been dem-
onstrated by the selective depletion of CD4
 
 
 
 T cells in
vivo (1–3) and by the adoptive transfer of CD4
 
 
 
 T cells to
immunocompromised mice (3–7). Recent studies of two
of the leading malaria vaccine candidate antigens, the 19-kD
carboxyl-terminal segment of merozoite surface protein 1
 
(MSP1
 
19
 
)
 
*
 
 and apical membrane antigen 1, have further con-
solidated previous findings. It has been shown that immunity
to 
 
Plasmodium yoelii YM
 
 after immunization with MSP1
 
19
 
,
relies upon MSP1
 
19
 
-specific T cells that help B cells con-
tinue synthesis of antibody after challenge (8, 9). Effector
CD4
 
 
 
 T cells, on the other hand, acting independently of
antibody, have been shown to contribute to protective
immunity to 
 
Plasmodium chabaudi
 
 infection after apical
membrane antigen 1 immunization (10). As in mice, CD4
 
 
 
T cells are thought to have a major role in regulating the
human immune response to 
 
Plasmodium falciparum
 
 infec-
tion. Human CD4
 
 
 
 T cells have been shown to inhibit
parasite growth in vitro (11). T cell–dependent production
of antiparasite antibodies occurs after T cell stimulation
with antigen in T cell–B cell cooperative systems in vitro
(12, 13). In vitro stimulation of CD4
 
 
 
 T cells with malaria
antigens may also result in proliferation and/or IFN secre-
tion, neither of which is correlated with levels of serum an-
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mediated dUTP nick-end labeling. 
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tibody against corresponding antigens (14–16). In vitro
stimulation may also induce IL-4 secretion that in individ-
ual donors is correlated with neither lymphocyte prolifera-
tion nor IFN-
 
 
 
 release, but rather with concentrations of
the relevant serum antibody (17, 18). These results suggest
that the human response is controlled by distinct CD4
 
 
 
 T
cell subsets that correspond in part to the TH1- and TH2-
like cells found in 
 
P. chabaudi
 
–infected mice (19). These
data suggest that both helper and effector functions of
CD4
 
 
 
 T cells contribute to immunity to malaria infection
in both mice and people.
Despite the critical roles of CD4
 
 
 
 T cells in controlling
malaria infection, immunity to malaria is slow to develop,
typically taking more than 5 yr for individuals in endemic
areas (20). The reasons for this are not well defined. It could
result from poor immunogenicity of malaria antigens (21),
antigenic variation and polymorphism (22–24), or from
host immunosuppression resulting from malaria infection
(25). It is well known that antigen-driven deletion or an-
ergy of immunological responses is a major regulatory strat-
egy to control potentially harmful responses (26). However,
these mechanisms might be used by infectious organisms to
enable their survival (27, 28). Indeed, previous work from
our group has shown that 
 
P
 
. 
 
berghei
 
–specific CD4
 
 
 
 T cells
that had been adoptively transferred into nude mice were
depleted after challenge with homologous parasites (29). As
such, further investigation of the mechanism and signifi-
cance of the depletion of parasite-specific T cells during in-
fection would provide insight into the nature of immunity
to malaria infection and would have a significant impact on
future malaria vaccine development strategies.
In this study, we show that protective parasite-specific
CD4
 
 
 
 T cells are depleted by both lethal and nonlethal spe-
cies of rodent malaria parasites. We further show that deple-
tion only affects parasite-specific CD4
 
 
 
 T cells and that
IFN-
 
 
 
 is involved in the process. We also demonstrate that
protective immunity to malaria infection is significantly af-
fected by such depletion of parasite-specific CD4
 
 
 
 T cells.
 
Materials and Methods
 
Mice and Parasites
 
Female inbred BALB/c (H-2
 
d
 
), BALB/c nu/nu, and C57BL/6J
(Thy1.2, H-2
 
b
 
) mice were purchased from Animal Resources
Centre. C57BL/6J-
 
 
 
m chain knockout (B cell KO) mice (30)
were obtained from The Centenary Institute for Cancer Medicine
and Cell Biology (Sydney, Australia) and bred in our animal facil-
ity. C57BL/6J Thy1.1 mice, C3H (H-2
 
k
 
) mice, and C3H Lpr
(Fas-deficient) mice were obtained from The Walter and Eliza
Hall Institute of Medical Research (Melbourne, Australia). TNF-
RI knockout (H-2
 
b
 
) mice were supplied by Australian National
University (Canberra, Australia). All mice ranged in age from 6 to
8 wk when experiments were initiated.
 
Plasmodium berghei ANKA, Plasmodium vinckei, P. chabaudi 
adami, P. yoelii 17XNL, and P. yoelii YM Parasites
 
The parasites were maintained by passage through donor mice.
Parasitemia was monitored by examining DiffQuick-stained (Lab
Aids Pty. Ltd.) blood smears under an oil immersion lens. To pre-
pare antigen for in vitro stimulation and immunization, blood
was collected from infected mice, washed twice with Eagle’s
minimal essential medium (EMEM; Trace Biosciences), resus-
pended to 10
 
8
 
 cells/ml, and stored at 
 
 
 
20
 
 
 
C until used. Parasit-
ized red blood cell (pRBC) lysate was prepared by freeze-thawing
pRBCs (6 
 
 
 
 10
 
8
 
 per ml) three times followed by sonication.
 
Generation of Parasite- and OVA-specific CD4
 
 
 
 T Cell Lines
 
T cell lines were generated from the lymph node cells of mice
immunized with crude parasite antigen or OVA protein (Sigma-
Aldrich). The mice were briefly immunized in the hind footpads
with 3 
 
  
 
10
 
7
 
 pRBCs or 100 
 
 
 
g of OVA protein emulsified in
CFA (H37Ra; Difco Laboratories). 7–9 d after immunization,
draining inguinal and popliteal lymph node cells were removed
and suspended at 2 
 
 
 
 10
 
6
 
 cells/ml in culture medium consisting
of EMEM supplemented with 10% FCS, 100 U/ml benzyl peni-
cillin (CSL Ltd.), and 5 
 
  
 
10
 
 
 
5
 
 M of 2-mercaptoethanol (Sigma-
Aldrich). Cells were dispensed in 24-well cluster plates (Corning
Glass Works) containing 10
 
6
 
 pRBC/ml or 100 
 
 
 
g/ml of OVA
protein. After 4 d, viable cells were isolated on Ficoll-Paque
(Amersham Pharmacia Biotech), washed, and dispensed in 24-
well plates containing irradiated (2,500 rad) syngeneic spleen cells
(APCs) at 2 
 
 
 
 10
 
6
 
 per ml in the absence of antigen for 7 to 10 d
(rest phase). For expansion, the rested cells were restimulated
with antigen in the presence of APCs (2 
 
 
 
 10
 
6
 
 cells/well).
The specificity of T cells was assessed by T cell proliferation as-
says. After 7–10 d of rest, viable T cells were isolated by Ficoll-
Paque gradient centrifugation, washed, and resuspended at 10
 
6
 
cells/ml in proliferation medium. 100 microliters of this suspen-
sion was added to 96-well flat-bottom plates containing 10
 
6
 
 APCs
and appropriate antigens. The cells were cultured for 4 d.
[
 
3
 
H]thymidine (0.5 
 
  
 
of
 
 
 
Ci in 25 
 
 
 
l of EMEM; Dupont) was
added to each well for the final 12–18 h of culture. Cells were
harvested onto filter mats (Wallac Oy) and the incorporated ra-
dioactivity was determined in a liquid scintillation counter. Re-
sults are expressed as mean counts per minute 
 
 
 
 1 SEM.
 
Characterizing T Cell Lines
 
Phenotypic Marker.
 
The phenotypes of established T cell lines
were analyzed by FACS
 
®
 
 analysis (Becton Dickinson). 10
 
6
 
 rested
T cells were incubated at 4
 
 
 
C for 30 min with 50 
 
 
 
l of undiluted
hybridoma supernatants. After two washes, cells were incubated
for an additional 30 min at 4
 
 
 
C with 50 
 
 
 
l of FITC-labeled goat
anti–rat IgG or goat anti–hamster IgG (Caltag), washed, and fixed
in 1% paraformaldehyde in PBS. Fluorescence was analyzed using
a FACSCalibur
 
®
 
 flow cytometer with the use of CellQuest™
software (Becton Dickinson). For each sample, 10,000 events
were counted and the percentage of positive cells was determined
after correction for nonspecific fluorescence. The following rat
IgG mAbs were used for staining: anti-CD3 (KT3), provided by
T. Mandel (The Walter and Eliza Hall Institute of Medical Re-
search, Melbourne, Australia); anti-CD8 (53-6.72; American
Type Culture Collection [ATCC], catalog number TIB 105);
anti-B220 (ATCC catalog number TIB 146), purchased from
ATCC; and anti-CD4 (GK1.5). Hamster IgG mAbs included
anti-TCR
 
  
 
 (H57-597) provided by T. Mandel and anti-
TCR
 
  
 
 (GL3-1A) provided by K. Shortman
 
 
 
(The Walter and
Eliza Hall Institute of Medical Research).
 
Cytokine Assays.
 
Cell-free culture supernatants were col-
lected after 24, 48, and 72 h of incubation for measurement of
IL-4 and IFN-
 
 
 
 activity. IL-4 was measured by ELISA according
to the method described by Doyle et al. (31). In brief, PVC plates 
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(ICN Biomedicals) were coated with protein-G–purified rat anti–
mouse IL-4 mAb BVD4-1D11 at a concentration of 5 
 
 
 
g/ml.
After coating and between each incubation step, plates were
washed three times with PBS-Tween 20. Plates were blocked for
1 h at 37
 
 
 
C with 1% BSA in PBS-Tween 20 before samples of
supernatants in PBS-Tween 20 were added to individual wells.
After a 1-h incubation at 37
 
 
 
C, 100 
 
 
 
l of a biotinylated BVD6-
24G2 anti–IL-4 mAb was added for 1 h at 37
 
 
 
C, followed by the
addition of 100 
 
 
 
l/well streptavidin–horseradish peroxidase con-
jugate (Vector Laboratories). Color was developed with 2,2
 
 
 
-azi-
nobis (3-ethylebzthiazoline-6-sulphonic acid) at 0.55 
 
 
 
g/ml in
0.1 M of citrate (pH 4.4) with 0.1% H
 
2
 
O
 
2
 
 (Sigma-Aldrich). Fi-
nally, the plates were read at 415 nm. Titers in bulk culture su-
pernatants were determined from the linear portion of parallel
dose–response curves by comparison with titrations of baculovi-
rus-derived murine IL-4 and expressed in arbitrary units (in
which 1 U/ml is defined as the concentration stimulating half-
maximal proliferation of the IL-4–responsive cell [CT.4S]). Su-
pernatants from limiting dilution cultures were assayed at a single
concentration of 50%. Positive supernatants were defined as those
that exceeded the value for control wells by at least 3 SD without
responders. For measuring IFN-
 
 
 
, ELISA kit (BD PharMingen)
was used according to manufacturer’s instruction protocol. rIFN-
 
 
 
(Sigma-Aldrich) was used as a standard control.
 
Functional Study of the Role of Generated T Cell Lines. P.  yoelii–
 
or OVA-specific CD4 T cells were harvested after 7–10 d of rest
in bulk culture and enriched over a Ficoll-Paque gradient (400 
 
g
 
for 20 min). 10
 
6 
 
viable T cells were resuspended in 200 
 
 
 
l of PBS
and injected intravenously via the lateral tail vein into B cell KO
mice. The mice were then infected with 10
 
5 P. yoelii parasites.
Parasite densities were monitored by microscopic examination of
tail blood films during the course of infection.
In Vivo Monitoring of T Cells
Parasite- (from different species) or OVA-specific T cell lines
were stained with 5- and 6-carboxyfluorescein diacetate succin-
imidyl ester (CFSE; Molecular Probes) as described by Lyons and
Parish (32). T cells were briefly resuspended at 107 cells/ml in
PBS. A 5-mM stock solution of CFSE in dimethyl sulfoxide was
added to a final concentration of 10  M and cells were incubated
for 30 min at 37 C. After incubation, cells were washed twice
with EMEM and resuspended in PBS. 107 labeled cells were
adoptively administered to mice (three to five mice per group),
and some of these mice were challenged 24 h later with 105 live
parasites. Mice were killed at various days after challenge and pe-
ripheral blood, spleen, inguinal lymph nodes, liver, lungs, and
bone marrow from two femurs were collected. Single cell sus-
pensions were prepared by Ficoll-Paque centrifugation for pe-
ripheral blood lymphocytes by flushing through bone marrow
and pressing through stainless meshes for cells from spleen, lymph
nodes, liver, and lungs. Cells were washed and resuspended in
0.1% BSA/0.1% NaN3/PBS and analyzed using a FACSCalibur®
flow cytometer. For analysis, 200,000–500,000 cells were
counted. In another approach to study the fate of transferred cells,
1.5   107 T cells generated in Thy1.2 C57BL/6J wild-type mice
were adoptively transferred to Thy1.1 C57BL/6J mice. The
transferred T cells were then analyzed using PE-labeled anti-
Thy1.2 mAb (BD PharMingen) as described above.
Apoptosis Assays
Annexin V Staining. Early stage apoptosis was detected using
the Annexin-V-Fluos staining kit (Boehringer). 106 cells were
briefly washed once with PBS, resuspended in 100  l of staining
solution, and incubated for 10–15 min at room temperature. Ap-
optotic cells were then analyzed by using a FACSCalibur® flow
cytometer. Propidium iodide was used to exclude necrotic cells.
To identify the source of apoptotic cells, a double staining method
was applied. GK1.5, M1/70, and 8c5 mAb (Caltag) were used for
staining CD4 T cells, macrophage, and granulocytes, respectively.
TdT-mediated dUTP Nick-end Labeling (TUNEL) Method.
Late stage apoptosis was detected using the in situ cell death de-
tection kit (Boehringer). 106 cells were briefly washed once with
PBS and then resuspended in 100  l of 4% freshly prepared
paraformaldehyde solution and fixed for 1 h at room tempera-
ture. After being washed twice, the fixed cells were permeabi-
lized in 0.1% Triton X-100 solution for 2 min on ice at 4 C. The
cells were then washed twice in PBS and resuspended in 50  l of
TUNEL reaction mixture for 60 min at 37 C in a humidified at-
mosphere in the dark. Finally, apoptotic cells were analyzed using
a FACSCalibur® flow cytometer.
Determination of Immunity to Parasite Infection after
T Cell Depletion
P. berghei–specific CD4 T cells were harvested and transferred
into BALB/c nu/nu mice as described above. The mice were
then infected with 105 homologous parasites and treated with py-
rimethamine (1 mg daily) on days 3, 4, 5, and 14 after infection. 2
wk later, mice were challenged again with 105 P. berghei pRBC.
Parasite densities were monitored by microscopic examination of
tail blood films during the course of infection.
Antibody Assay
P. berghei–specific antibodies in sera were measured using
ELISA. PVC plates (ICN Biomedicals) were coated overnight at
4 C with 0.2  g/ml of crude pRBC antigen. Plates were washed
three times after coating and between each incubation step with
PBS-Tween 20. Plates were blocked for 1 h at 37 C with 1%
BSA in PBS-Tween 20 before samples of serum diluted in PBS-
Tween 20 were added to individual wells. After a 1-h incubation
at 37 C, 100  l of a 1:3,000 dilution of peroxidase-conjugated
sheep anti–mouse IgG (The Binding Site) was added for 1 h at
37 C, followed by the addition of 100  l/well of 2,2 -azino-
di-[ethyl-benzthiozolin sulfonate] (Sigma-Aldrich). After 30 min,
the absorbance of each well was read at 405 nm. Serially diluted
sera were used to determine antibody titers.
Statistical Analysis
Comparisons among experimental groups by Student’s t test
were performed using a statistical analysis program of Sigma Plot
for Windows version 4.0. Significance was set at P   0.05.
Results
Generation of Parasite-specific T Cell Lines.  Mice were
immunized with pRBC lysates or OVA protein. 7–9 d af-
ter immunization, single cell suspensions from draining in-
guinal and popliteal lymph node cells were cultured with
antigen as described in Materials and Methods. After four
cycles of stimulation and rest, the cell lines were character-
ized by FACS® analysis and bioassay for cytokine produc-
tion. T cell lines generated to all the species of Plasmodium
in this report have a similar phenotype and cytokine pro-
duction profile. The data in Fig. 1 are for P. yoelii 17 XNL.
The established lines were composed of 99.8% CD4  T884 CD4  T Cells in Malaria Infection
cells with 99.6% TCR   expression (Fig. 1 A). Their
specificity was confirmed by proliferation assays (Fig. 1 A).
These T cell lines produced IFN-  without detectable IL-4
as measured by bioassay (Fig. 1 B). To assess function of
these generated T cell lines, they were administered to B
cell KO mice. After homologous parasite challenge, the B
cell KO mice that had received the T cells had significantly
lower parasitemia than the control mice that received
OVA-specific T cells over the course of infection (Fig. 1
C; P   0.01).
Both Lethal and Nonlethal Strains of Plasmodium Cause De-
pletion of Parasite-specific CD4  T Cells. To monitor para-
site-specific T cells in vivo, they were either labeled with
CFSE and adoptively transferred to syngeneic mice, or we
relied on an allelic marker to track cells. Initially, P. yoelii
17 XNL–specific T cells generated from BALB/c mice
were labeled with CFSE and were monitored by FACS®
analysis after transfer to syngeneic mice. Division was dem-
onstrated by the sequential halving of the intensity of the
fluorescent signal in the cells (32). After transfer, CFSE T
cells in the spleen displayed a single peak in normal BALB/c
mice by day 6 (Fig. 2 A). Although spleen sizes increased
and some parasite-specific T cells divided after infection
with P. yoelii 17 XNL, labeled cells were undetectable by
day 6 (Fig. 2 A). This was first evident by day 4 after chal-
lenge, and by day 6 there were less than 0.01% CFSE T
cells detectable (Fig. 2 A). This decrease was not reflected
in an increased number of CFSE-labeled cells in other tis-
sues. Cells were monitored in blood, lung, liver, bone mar-
row, and lymph nodes. Infection by day 6 resulted in an
apparent decrease of parasite-specific cells in all locations
(Fig. 2 B; P   0.05).
To further assess the fate of T cells after infection and to
compare the responses to lethal and nonlethal infections,
CFSE-labeled T cell lines specific for both nonlethal (P.
chabaudi) and lethal species (P. vinckei and P. yoelii YM)
were adoptively transferred to BALB/c nude mice. As
shown in Fig. 3 A, the absolute numbers of CFSE-labeled
T cells in the spleens were significantly decreased in in-
fected mice compared with uninfected mice by day 6 after
Figure 1. (A) Phenotype and specificity of generated
T cell lines. After four cycles of stimulation of P. yoelii
17 XNL–specific T cell line, cell surface markers were
measured by FACS® analysis. The specificity was deter-
mined by proliferation assay for T cell lines after four
cycles of stimulation. (B) Cytokine production. IL-4
and IFN-  production by P. yeolii 17 XNL–specific T
cell line were measured by ELISA. Data show U/ml
for IL-4 and IFN-  production. (C) Protective role of
transferred parasite-specific T cells. C57BL/6J B cell
KO mice were administered P. yoelii 17 XNL–specific
T cells ( ) or OVA-specific T cells ( ) followed by
challenge with P. yoelii 17 XNL parasites 24 h later.
Parasitemia was monitored every second day. Signifi-
cantly lower peak parasitemias (less than 5% parasitemia
over the course of infection) were observed in the mice
that received P. yoelii 17 XNL–specific T cells com-
pared with the mice that received OVA-specific T cells
(P   0.01). The figure represents one of four indepen-
dent experiments with similar findings.885 Xu et al.
transfusion (2.52   105   0.91 vs. 0.63   105   0.19, P  
0.01, for P. Chabaudi–specific T cells; 4.19   105   1.47
vs. 1.47   105   0.37, P   0.01, for P. vinckei–specific T
cells; and 4.0   105   0.60 vs. 1.90   105   0.30, P  
0.01, for P. yoelii YM–specific T cells). To confirm the de-
letion, the numbers of CD4  T cells were also assessed. It
was found that CD4  T cells in the spleen were not de-
tected at levels above uninfected nude mice for all tested
parasite-specific T cell lines (Fig. 3 B).
To formally exclude the possibility that parasite-specific
T cells had undergone division in vivo, to the extent that
the CFSE label was reduced beyond detection, an allelic
marker was used to track transferred T cells. We demon-
strated that transferred C57BL/6J Thy1.2 T cells specific
to P. yoelii 17XNL parasites were deleted in the spleen
(Fig. 4) and other tissues (unpublished data) in infected
C57BL/6J Thy1.1 mice, but survived in noninfected con-
trol mice.
Depletion Only Affects Parasite-specific CD4  T Cells.
To determine whether depletion was limited to parasite-
specific CD4  T cells, OVA-specific CD4  T cell lines
were adoptively transferred to nude mice. Although spleen
sizes increased after infection with P. berghei, there was a
slight reduction in the percentage of OVA-specific T cells
Figure 2. (A) Depletion of parasite-specific CD4  T cells by malaria
infection. BALB/c mice (three to four mice per group) were adminis-
tered labeled P. yoelii 17 XNL–specific T cells, followed by challenge
with homologous parasites. Control mice received labeled T cells without
infection. Spleens from control mice were collected by day 6 after cell
transfusion (upper panel). Spleens from infected mice were collected by
day 2 (second panel), day 4 (third panel), or day 6 (bottom panel) after
cell transfusion and malaria infection. Percentage of positive CFSE-
labeled cells in spleens is indicated in FACS® profiles. Each FACS® pro-
file represents one individual mouse. The figure represents one of two in-
dependent experiments with similar findings.  The numbers of donor
CFSE cells was significantly lower on day 6 in infected mice (P   0.01)
and there were less than 0.01% CFSE T cells detectable. (B) Depletion of
parasite-specific T cells in other tissues. Day 6 after cell transfusion, the
absolute numbers of CFSE-labeled P. yoelii 17 XNL–specific T cells were
measured in both infected and noninfected mice in all locations including
per spleen, per ml of blood (PBL), per two femurs of bone marrow (BM),
per two inguinal and two popliteal lymph nodes (LN), per liver, and per
two lungs. Data represent mean cell numbers   1 SEM.  , noninfected
mice had significantly higher numbers of CFSE T cells (P   0.05).
Figure 3. Depletion of parasite-specific CD4  T cells by both lethal
and nonlethal species of malaria parasites. (A) BALB/c nude mice (three
to four mice per group) were administered labeled P. chabaudi–specific, P.
vinckei–specific, or P. yoelii YM–specific T cells. Some mice were then
challenged with homologous parasites. Spleens were collected at day 6 af-
ter challenge. The absolute numbers of CFSE-labeled cells in the spleens
were counted. Data represent mean cell numbers   1 SEM.  , signifi-
cantly lower numbers of CFSE-labeled T cells were observed in infected
mice by day 6 after transfusion in all tested parasite species (P   0.01). (B)
The absolute numbers of CD4  T cells (by day 6 after challenge) in the
spleens of both infected and noninfected mice are shown. Background
levels of CD4  T cells from naive nude mice are also shown. Data repre-
sent mean cell numbers   1 SEM.  , significantly lower numbers of
CD4  T cells in infected nude mice were observed in all tested parasite-
specific T cell lines (P   0.01).886 CD4  T Cells in Malaria Infection
compared with uninfected mice (Fig. 5 A). However,
when corrected for spleen size, there was no diminution of
OVA-specific T cells in the spleens of infected mice
(1.77   105   0.24 vs. 1.74   105   0.53).
We then asked whether depletion was triggered by anti-
gen per se. Thus, nude mice that had been administered
OVA-specific T cells were directly challenged with varying
doses of OVA antigen ranging from 1 to 1,000  g. OVA
Figure 4. Deletion determined by using allele type
markers. Thy1.1 C57BL/6J mice (three to four mice
per group) were administered Thy1.2 P. yoelii 17
XNL–specific T cells followed by challenge with ho-
mologous parasites. Control mice received T cells with-
out infection. Spleens from control mice were collected
by day 6 after cell transfusion (top). Spleens from in-
fected mice were collected by day 6 (bottom) after cell
transfusion and malaria infection. Percentage of posi-
tive Thy1.2 cells in spleens is indicated in FACS® pro-
files. Each FACS® profile represents one individual
mouse.  The number of donor cells was significantly
lower in infected mice on day 6 using Thy1.2 to mark
the cells (P   0.01).
Figure 5. Effect of infection on OVA-specific T cells in
nude mice. (A) Nude mice were administered OVA-spe-
cific CD4  T cells and followed by challenge with P.
berghei parasites (bottom) or no challenge (top). Spleens
were collected on day 6 after cell transfusion. Labeled cells
in spleens were subsequently detected by FACS® analysis.
Percentage of positive CFSE-labeled cells in spleens is
shown in FACS® profiles. The figure represents one of five
independent experiments with similar findings. Each
FACS® profile represents one individual mouse. There was
no significant diminution of OVA-specific T cells in the
spleens of infected mice (P   0.05). (B) Mice (three mice
per group) that had been administered OVA-specific T
cells were either directly challenged, or not challenged as
controls, with different doses of OVA antigen as indicated
in the figure. The data given are for the absolute numbers
of splenic CD4  cells in mice challenged by different doses
of OVA. Data represents mean cell numbers   1 SEM. (C)
Mice (three mice per group) were administered CFSE-
labeled P. berghei–specific T cells (upper and second panel)
or both CFSE-labeled OVA-specific T cells and nonla-
beled P. berghei–specific T cells (third and bottom panel).
Some mice were infected by P. berghei parasites as indicated
in the figure. Spleens were collected on day 6 after cell
transfusion. Percentage of positive CFSE-labeled cells in
spleens is shown in FACS® profiles. The figure represents
one of two experiments with similar findings. Each FACS®
profile represents one individual mouse. Deletion of ma-
laria-specific T cells did not result in the depletion of by-
stander CFSE OVA T cells (P   0.05).887 Xu et al.
challenge resulted in an increased number of splenic CD4 
T cells for all doses of antigen (Fig. 5 B).
To determine whether depletion of parasite-specific T
cells affects bystander T cells, mice were administered both
CFSE-labeled OVA-specific and nonlabeled P. berghei–spe-
cific T cells. As shown in Fig. 5 C, malaria infection re-
sulted in the depletion of CFSE-labeled P. berghei–specific
T cells in the control group and some diminution in the
percentage of CFSE-labeled OVA-specific T cells in the
mice that had received both CFSE-labeled OVA-specific
and nonlabeled P. berghei–specific T cells. When an abso-
lute number of CFSE OVA T cells were enumerated, there
was an increase in the number of CFSE OVA T cells in the
spleens of infected mice versus noninfected mice (3.5  
105   0.25 vs. 2.96   105   0.18) although the difference
was not statistically significant (P   0.05).
Acquired Immunity to Malaria Infection Is Significantly Re-
duced after the Depletion of Parasite-specific CD4  T Cells.
To determine whether immunity to malaria infection is af-
fected by the depletion of parasite-specific CD4  T cells,
P. berghei– or OVA-specific T cells were adoptively trans-
ferred to nude mice. Some mice were then given a pulse
infection with homologous parasites followed by treatment
with pyrimethamine 3, 4, 5, and 14 d after infection with
the intention of deliberately depleting parasite-specific T
cells, but enabling the mice to survive infection. Successful
pyrimethamine treatment was confirmed by checking
blood films and transferring blood to naive reporter mice. 2
wk after treatment, the mice were rechallenged. Mice that
had received parasite-specific T cells and been previously
infected and treated with pyrimethamine had significantly
higher levels of parasitemia than mice that received para-
site-specific CD4  T cells without previous infection
(18.0%   2.1 vs. 3.1%   0.7 on day 8; 25.0%   2.1 vs.
7.2%   1.7 on day 10; and 26.6%   1.0 vs. 10.7%   2.5
on day 12; P   0.01), although they still had significantly
lower levels of parasitemia than nude mice that received no
T cells or OVA-specific T cells (Fig. 6 A; 18.0%   2.1 vs.
29.2%   3.1 or 26.2%   2.8 on day 8; 25.0%   2.1 vs.
35.5%   6.1 or 37.7%   3.4 on day 10; and 26.6%   1.0
vs. 35.6%   3.7 or 44.3%   3.6 on day 12; P   0.01). Al-
though recipients of parasite-specific T cells that were ini-
tially infected were subsequently less immune, recipients
alone developed a low titer antibody response on day 8 af-
ter challenge (Fig. 6 B). Thus, these data suggest that cellu-
lar immunity to malaria infection was impaired as a result of
their initial exposure to parasites.
Mice Infected with Malaria Parasites Have Significantly Higher
Levels of Apoptosis.  To investigate the mechanism of de-
pletion of parasite-specific T cells, we measured apoptosis
during infection. Using an early stage apoptosis Annexin V
detection kit, apoptosis was detectable in splenic cells as
early as 24 h after infection (Fig. 7 A). Using dual staining,
we found that from the various cell populations studied,
CD4  T cells alone demonstrated increased apoptosis after
infection (Fig. 7 B). Using the TUNEL method, it was
found that by day 6 after challenge, infected mice had sig-
nificantly higher levels of apoptosis in the spleen compared
with uninfected mice (Fig. 7 C; 21.48   3.10% vs. 7.25  
0.32%, P   0.01).
Depletion of Parasite-specific CD4  Cells after Infection Is
Not via TNF or Fas Pathway.  To identify the pathway of
apoptosis in malaria infection, P. berghei–specific T cell lines
were generated in TNF-RI knockout– and Fas-deficient
(C3H Lpr) mice. Similarly to wild-type mice, the estab-
lished T cell lines generated from these mice consisted of
99% CD4  cells with 99% TCR   expression, and cells
secreted IL-2 and IFN-  (unpublished data). Because the
mice lack either TNF-RI or Fas, they will not receive sig-
nals from TNF or Fas ligand, respectively. Accordingly, if
apoptosis is mediated via the TNF or Fas pathways, the T
cell lines generated from these mice will not be depleted.
Using the same approach as described above, CFSE-labeled
Figure 6. (A) Parasitemia in nude mice after infection-induced deple-
tion of parasite-specific T cells. P. berghei–specific T cells were adoptively
transferred to nude mice (five mice per group). One group of mice ( )
were then infected with homologous parasites followed by treatment with
pyrimethamine on days 3, 4, 5, and 14. Another group of mice only re-
ceived P. berghei–specific T cells without infection and treatment ( ).
Control mice received no T cells ( ) or OVA-specific T cells ( ). All
groups of mice were challenged with P. berghei parasites at the same time
as those mice ( ) that had received pyrimethamine treatment (14 d after
the last dose of pyrimethamine). Parasitemia was monitored every second
day. Data represent mean parasitemia   1 SEM. #, mice that had received
parasite-specific T cells and had been previously infected and treated with
pyrimethamine had significantly higher levels of parasitemia than mice
that received parasite-specific CD4  T cells without previous infection
(P   0.01), but had lower levels of parasitemia than nude mice that re-
ceived no T cells or OVA-specific T cells (P   0.01);  , death of mice.
(B) Antibody levels. Sera from different groups of mice as indicated above
were collected before and after challenge, and anti-P. berghei antibody ti-
ters were measured by ELISA. Data represents mean titer   1 SEM.888 CD4  T Cells in Malaria Infection
parasite-specific T cells generated from these mice were
adoptively transferred to wild-type mice. After challenge,
the transferred T cells were undetectable by day 6 (Fig. 8),
suggesting that the depletion of parasite-specific CD4  T
cells during infection is not mediated by either TNF or Fas.
IFN-  Contributes to the Depletion of Parasite-specific CD4 
T Cells in Malaria Infection.  To determine whether IFN- 
plays a role in the apoptosis in malaria infection, CFSE-
labeled P. berghei–specific T cells were adoptively transferred
to nude mice. The mice were then administered 1 mg daily,
1, 2, and 3 d after challenge, of either anti–IFN-  antibody
XMG-6 (33) or an isotype-matched control antibody (GL-
113). Similarly to previous experiments, T cells were de-
pleted in the mice that were infected and also received con-
trol antibody (Fig. 9 A). In contrast, T cells underwent mul-
tiple divisions in the infected mice that had simultaneously
received anti–IFN-  antibody (Fig. 9 A). When the abso-
lute numbers of CFSE-labeled cells were counted in the
spleens, mice that had received anti–IFN-  antibody had
significantly higher levels of T cells compared with mice
that were not infected or were infected and received isotype
control antibody (Fig. 9 B; 22.7   104   3.81 vs. 10.9  
104   3.52 or 5.7   104   1.04, P   0.01). These data sug-
gest that IFN-  is necessary for the depletion of parasite-
specific CD4  T cells during malaria infection.
Discussion
This study demonstrates that apoptotic deletion of para-
site-specific CD4  T cells is a common occurrence after
infection with different species of rodent malaria parasites
and can lead to impaired T cell–mediated immunity. Dele-
tion requires more than antigenic stimulation alone. IFN- 
is involved in this process, but engagement of Fas or TNF-
RI is not required.
The central role of CD4  T cells in protective immunity
to blood stage malaria infection has been shown in both
murine and human studies (34, 35). Despite the potential
for CD4  T cells to contribute to protective immunity,
natural immunity to malaria is slow to develop (20). The
mechanisms for this remain to be defined and are the sub-
ject of intense investigation. To address this question, we
first generated parasite-specific T cell lines by immunizing
mice with pRBC lysates. These T cell lines were TH1-like
(Fig. 1, A and B). T cells were adoptively transferred to B
cell KO mice and provided partial protection against chal-
lenge with homologous parasites (Fig. 1 C). Because B cell
KO mice cannot produce antibody, the control of para-
sitemia must be dependent on the transferred cells and in-
dependent of antibody. Thus, these data indicate that the
established parasite-specific T cells have a protective role
(36). Using established TH1-like T cell lines, we studied
the fate of malaria parasite–specific T cell lines in vivo.
Consistent with our previous report (29), the current study
showed that transferred T cells were depleted in mice after
infection. We have extended these observations by show-
ing that depletion started as early as day 4 after challenge
and was completed by day 6 (Fig. 2 A). Furthermore, we
demonstrated that lethal and nonlethal strain parasite-spe-
cific T cells undergo a similar depletion process in vivo af-
ter infection (Fig. 3, A and B, and Fig. 5 C). This indicates
that depletion of transferred parasite-specific T cells is a
common phenomenon in malaria and may be a strategy
used by malaria parasites to eliminate T cells and evade host
defenses that can act to limit the infection, as shown in
other systems (37, 38).
Significantly, in this study, we showed that the depletion
during malaria is confined to parasite-specific CD4   T
cells. The evidence comes from three separate sets of ex-
periments. First, OVA-specific CD4  T cell lines were not
Figure 7. Apoptosis in mice infected with malaria parasites. Mice
(three to four per group) were infected with P. berghei parasites. (A) At
various days after challenge, spleens were removed and apoptosis was de-
termined by an early stage apoptosis detection kit Annexin V. (B) Apop-
tosis of different types of cells were measured by a double staining
method. (C) TUNEL method was used to detect late stage apoptosis in
spleens by day 6 after P. berghei parasite infection. Percentage of apoptotic
cells in infected mice and noninfected mice is indicated in individual
FACS® profiles. The figures represent one of many independent experi-
ments (including ones that use different strains of parasite infections) with
similar findings. All data represent mean percentage   1 SEM. Signifi-
cantly higher levels of apoptosis in the spleen were observed in infected
mice (P   0.01).889 Xu et al.
depleted by malaria infection (Fig. 5 A). Secondly, instead
of depletion, OVA-specific T cells were activated and di-
vided in response to direct challenge with a range of doses
of OVA antigen (Fig. 5 B). This suggests that at least in the
short term, only parasite-specific T cells are depleted once
they are engaged by their specific parasite antigen. Finally,
using a dual transfusion system, we showed that depletion
of parasite-specific T cells did not kill bystander OVA-spe-
cific T cells (Fig. 5 C). This strongly suggests that depletion
is programmed within the cell after TCR engagement by
appropriate parasite antigens. The fact that dead antigen,
OVA, does not lead to the depletion of OVA-specific T
cells, and that malaria infection did not cause the bystander
killing of OVA-specific CD4  T cells (Fig. 5), strongly
suggest that other elements of infection, apart from T cell
stimulation or cytokine release alone, are required for dele-
tion apoptosis of parasite-specific T cells.
T cell fate in vivo has been under intensive investigation
in many different systems (39–41). During immune re-
sponses, large numbers of activated effector T cells are gen-
erated. The majority of these cells are then eliminated by
apoptosis (42, 43). A balance of survival and apoptosis of
immune cells during infection is extremely important as it
may affect the generation of protective memory T cells and
may eliminate potentially harmful activated T cells. On the
other hand, apoptosis may well be induced by infectious
organisms to enable their survival. In this study, our data
suggest that apoptosis is a key factor involved in the deple-
tion of malaria parasite–specific CD4  T cells. This conclu-
sion comes from our observation that infected mice had
Figure 8. Depletion of parasite-
specific CD4  T cells generated
from TNF-RI knockout– or Fas-
deficient mice. P. berghei–specific T
cell lines generated from TNF-RI
KO– and Fas-deficient (C3H Lpr)
mice were adoptively transferred to
wild-type mice (three mice per
group). Some mice were then
challenged by homologous para-
sites. Spleens were collected by day
6 after T cell transfusion. The la-
beled cells in spleens were subse-
quently detected by FACS® analysis.
Percentage of positive CFSE-labeled
cells in spleens is shown in FACS®
profiles. Figures represent one of
two independent experiments with
similar findings. Each FACS® profile
represents one individual mouse.
Figure 9. The role of IFN-  in the apoptosis of malaria parasite infection. (A) CFSE-labeled P. berghei–specific T cells were adoptively transferred into
nude mice (three mice per group). One group of mice were injected with anti–IFN-  antibody (1 mg daily, on days 1, 2, and 3 after challenge) and
challenged with homologous parasites along with other control groups of mice as indicated in the figure. Spleens were collected by day 6 after T cell
transfusion. Labeled cells in spleens were then detected by FACS® analysis. Percentage of positive CFSE-labeled cells in spleens is shown in FACS® pro-
files. Each FACS® profile represents one individual mouse. (B) Absolute number of CFSE-labeled cells were counted in the spleens in different groups of
mice.  , mice that had received anti–IFN-  antibody had significantly higher levels of T cells compared with mice that were not infected or were in-
fected and received isotype control antibody (P   0.01).890 CD4  T Cells in Malaria Infection
significantly higher levels of early and later stage apoptotic
cells in the spleen compared with uninfected mice (Fig. 7,
A and C). Using a dual staining method, we also demon-
strated that from the range of cells studied, CD4  T cells
alone were apoptotic (Fig. 7 B). This has been further con-
firmed in our recent study that showed high levels of apop-
totic cells after infection in CFSE-labeled helper T cells
specific for the vaccine candidate homologue, MSP119 (44).
Apoptosis is strictly regulated through the interaction of
proapoptotic and antiapoptotic molecules. Three major
mechanisms have been found to be responsible for the ac-
tivation of the apoptotic machinery. These include the
withdrawal of survival signals like growth factors, the in-
tervention of conflicting signals during the cell cycle, or
the recognition of a specific molecule at the cell surface
(45). Of these three mechanisms, receptor-mediated sig-
naling is the best defined. Death receptors belonging to the
TNF receptor super family are transmembrane proteins lo-
calized to the cytoplasmic membrane. Well-characterized
death receptors are TNF-RI and CD95 (Fas) which bind
the cytokine TNF  and CD95 ligand (CD95L), respec-
tively (46–48). To attempt to find the pathway of apoptosis
in malaria infection, parasite-specific T cell lines were gen-
erated from TNF-RI knockout– and Fas-deficient mice.
Our data (Fig. 8) show that after challenge the parasite-
specific T cells generated from these knockout mice were
depleted, as were the T cells generated from wild-type
control mice, which suggests an alternative pathway is in-
volved in depletion.
The central role of cytokines contributing to protective
immunity and pathogenesis in malaria infection has been
demonstrated in numerous studies (49, 50). In particular,
IFN-  responses have been shown to be associated with
resistance to reinfection with P. falciparum in young Afri-
can children (51). On the other hand, IFN-  has been im-
plicated in the pathogenesis of experimental cerebral ma-
laria (52, 53). An early study also postulated IFN-  as a key
factor responsible for the cell death of effector CD4  T
cells and as a possible mechanism for self-tolerance (54).
Indeed, more recent studies have suggested that IFN-  is
responsible for eliminating responding CD4  T cells in
several other systems by inducing apoptosis of activated
CD4  T cells (55–57). To determine whether IFN-  plays
a role in apoptosis in malaria infection, CFSE-labeled P.
berghei–specific T cells were administered simultaneously
with anti–IFN-  antibody into nude mice. Nude mice
that received anti–IFN-  antibody had significantly higher
levels of CFSE-labeled parasite-specific T cells compared
with control mice (Fig. 9), indicating that IFN- , apart
from its role in killing parasites, contributes to the deple-
tion of parasite-specific CD4  T cells. Indeed, IFN-  has
been shown to induce apoptosis of mammalian cells in a
manner independent of Fas and TNFR (58). Whether
IFN-  alone or combined with other molecules such as
nitric oxide (59) regulates apoptosis in malaria infection
merits further investigation.
Although this study shows that impaired immunity
occurs after the depletion of protective parasite-specific
CD4  T cells during malaria infection, it is well known
that normal mice can be immunized by infection followed
by drug cure. In such mice it is likely that induced antibody
plays the critical role in protection. We observed (Fig. 6 B)
that infection did not prevent an antibody response in mice
that had received parasite-specific T cells. However, cell-
mediated immunity can control parasite growth (10). A
major challenge is to identify target antigens for cell-medi-
ated immunity and understand the regulation of it after in-
fection. Thus, this study, by defining a possible apoptotic
pathway, contributes to a better understanding of parasite
immunity that may lead to successful vaccine development.
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